• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqGS
    6.85 Down 0.15(2.14%) Feb 11, 4:00PM EST
    |After Hours : 6.85 0.00 (0.00%) Feb 11, 4:00PM EST
    Prev Close:7.00
    Open:6.85
    Bid:6.85 x 2000
    Ask:12.49 x 500
    1y Target Est:19.50
    Beta:1.0432
    Next Earnings Date:16-Feb-16CYTK Earnings announcement
    Day's Range:6.59 - 7.00
    52wk Range:5.50 - 13.18
    Volume:285,667
    Avg Vol (3m):499,181
    Market Cap:266.10M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 2.14%266.10M
    LGNDDown 2.80%1.71B
    BIIBDown 2.81%53.60B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.04
    Quarterly EPS Est (Dec-15) :-0.32
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback